NDC 51672-2075-01 - Bacitracin Zinc
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2075
- Requested NDC
- 51672-2075-01
- Package NDCs from labels
- 51672-2075-1, 51672-2075-2, 51672-2075-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bacitracin Zinc - A-S Medication Solutions | A-S Medication Solutions | 2026-08-07 | HUMAN OTC DRUG LABEL |
| Bacitracin Zinc Ointment USP | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2026-04-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2075-1 | Bacitracin Zinc | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 51672-2075-1 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 30 g in 1 TUBE | OINTMENT | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2075 | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241105_4afdeedf-9cdf-47d6-919f-ea907fda0290.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2075-1 | GM - Gram | 51672-2075 | e945b097-4fbc-49ee-be04-cda62ddd0a1b | 1 | 2013-02-13 |
| 51672-2075-2 | GM - Gram | 51672-2075 | 9d1461f6-ec4f-41a4-abbd-699c44ef8cb8 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Bacitracin Zinc | ACTIVE INGREDIENT | 89Y4M234ES | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Petroleum Skin Protectant | WHITE PETROLATUM | Major Pharmaceuticals | 0e7e11c5-a1f8-43c4-b8a6-211491052404 | 2026-02-04 | Warnings, Adverse reactions | 4T6H12BN9U |
| Double Antibiotic | BACITRACIN ZINC AND POLYMYXIN B SULFATE | STRATUS PHARMACEUTICALS INC | f64b3564-ea3c-4316-8f00-f92c08dcad35 | 2026-02-04 | Warnings | M004 89Y4M234ES |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Sportpharm LLC | 88e3624d-b8bb-4e65-9250-4c51d2bbed16 | 2026-02-03 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Comforts Petroleum Jelly | WHITE PETROLATUM | KROGER | 3feb3638-1cdc-62d4-e063-6294a90a1d89 | 2026-02-03 | Warnings | 4T6H12BN9U |
| Petroleum Skin Protectant | WHITE PETROLATUM | Demoulas Super Markets, Inc | 702215f0-4cfd-4a23-b47a-da691c136634 | 2026-02-03 | Warnings, Adverse reactions | 4T6H12BN9U |
| Vitamin A D | LANOLIN, PETROLATUM | Kroger Co. | b4aa9b58-d95e-4dac-9a34-213482e8ca34 | 2026-02-02 | Warnings, Adverse reactions | 4T6H12BN9U |
| Optase | WHITE PETROLATUM, LANOLIN | Scope Health Inc | c1991caa-51b9-13d1-e053-2995a90a1293 | 2026-01-31 | Warnings | 4T6H12BN9U |
| Lanolin, Petrolatum | LANOLIN, PETROLATUM | Rite Aid Corporation | 1b6d7cdf-e7bc-4fd4-939c-5eb0eaa1744d | 2026-01-30 | Warnings, Adverse reactions | 4T6H12BN9U |
| Pure petroleum | WHITE PETROLATUM | Rite Aid Corporation | f67be4cc-9983-4758-93c8-383919ec07ca | 2026-01-30 | Warnings, Adverse reactions | 4T6H12BN9U |
| Advanced Healing | PETROLATUM | Rite Aid Corporation | 0d535736-ba61-42eb-9112-c154295372a2 | 2026-01-30 | Warnings, Adverse reactions | 4T6H12BN9U |
| Drs. pharmacy triple antibiotic plus lidocaine | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, LIDOCAINE OINTMENT | OL PHARMA TECH, LLC | 49a73b0f-90d9-3a4b-e063-6294a90acfb0 | 2026-01-30 | Warnings | 89Y4M234ES |
| UNIVERSAL BABY FRESH SCENT PETROLEUM | WHITE PETROLEUM | Universal Distribution Center LLC | ec67a1ee-ad71-54f2-e053-2995a90a7690 | 2026-01-29 | Warnings | 4T6H12BN9U |
| Petroleum | WHITE PETROLATUM | 7-Select | 7e93df71-74bd-4d95-9a64-54756c7b234a | 2026-01-29 | Warnings, Adverse reactions | 4T6H12BN9U |
| TheraCare Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, AND PRAMIXINE HCL | Veridian Healthcare | d2374664-4668-4da5-9df7-44e6e421ad54 | 2026-01-29 | Warnings | M004 89Y4M234ES |
| TheraCare Bacitracin Zinc | FIRST AID ANTIBIOTIC | Veridian Healthcare | 8217648d-5acb-4a1e-913f-43695f4e01ad | 2026-01-29 | Warnings | M004 89Y4M234ES |
| TheraCare Diabetic Foot Cream | DIMETHICONE, PETROLATUM | Veridian Healthcare | 49132a75-4a16-cede-e063-6294a90a6217 | 2026-01-29 | Warnings | 4T6H12BN9U |
| TheraCare A and D | LANOLIN, PETROLATUM | Veridian Healthcare | 1303aa33-2111-b36c-e063-6294a90af131 | 2026-01-29 | Warnings | 4T6H12BN9U |
| Advanced Healing | PETROLATUM | Aldi, Inc | 94fea2f2-fea8-4923-afc6-36068bc2fef5 | 2026-01-29 | Warnings, Adverse reactions | 4T6H12BN9U |
| UNIVERSAL LAVENDER SCENT PETROLEUM | WHITE PETROLEUM | Universal Distribution Center LLC | 066b1313-aed8-9436-e063-6294a90a2b11 | 2026-01-29 | Warnings | 4T6H12BN9U |
| Mineral Oil | MINERAL OIL | CARDINAL HEALTH 110, LLC. DBA LEADER | 803f444f-d136-4f06-9842-24a71a3d7d6b | 2026-01-29 | Warnings, Adverse reactions | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.